product summary
Loading...
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human LAP (TGF-beta 1) Protein
catalog :
246-LP-025
quantity :
25 ug
price :
470 USD
more info or order :
R&D Systems product webpage
citations: 25
Reference
Roy A, Shi L, Chang A, Dong X, Fernandez A, Kraft J, et al. De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8. Nat Commun. 2023;14:5660 pubmed publisher
Haudenschild A, Sherlock B, Zhou X, Sheaff C, Hu J, Leach J, et al. Non-destructive, continuous monitoring of biochemical, mechanical, and structural maturation in engineered tissue. Sci Rep. 2022;12:16227 pubmed publisher
Wu W, Huang X, You Y, Xue L, Wang X, Meng X, et al. Latent TGF-β1 protects against diabetic kidney disease via Arkadia/Smad7 signaling. Int J Biol Sci. 2021;17:3583-3594 pubmed publisher
Zhou M, Niu J, Wang J, Gao H, Shahbaz M, Niu Z, et al. Integrin αvβ8 serves as a Novel Marker of Poor Prognosis in Colon Carcinoma and Regulates Cell Invasiveness through the Activation of TGF-β1. J Cancer. 2020;11:3803-3815 pubmed publisher
Basta J, Robbins L, Stout L, Prinsen M, Griggs D, Rauchman M. Pharmacologic inhibition of RGD-binding integrins ameliorates fibrosis and improves function following kidney injury. Physiol Rep. 2020;8:e14329 pubmed publisher
Briggs D, Langford Smith A, Birchenough H, Jowitt T, Kielty C, Enghild J, et al. Inter-α-inhibitor heavy chain-1 has an integrin-like 3D structure mediating immune regulatory activities and matrix stabilization during ovulation. J Biol Chem. 2020;295:5278-5291 pubmed publisher
Tsui P, Higazi D, Wu Y, Dunmore R, Solier E, Kasali T, et al. The TGF-? inhibitory activity of antibody 37E1B5 depends on its H-CDR2 glycan. MAbs. 2017;9:104-113 pubmed publisher
Jones K, Ballesteros A, Mentink Kane M, Warren J, Rattila S, Malech H, et al. PSG9 Stimulates Increase in FoxP3+ Regulatory T-Cells through the TGF-?1 Pathway. PLoS ONE. 2016;11:e0158050 pubmed publisher
Fan M, Zhu Q, Li H, Ra H, Majumdar S, Gulick D, et al. Fibroblast Activation Protein (FAP) Accelerates Collagen Degradation and Clearance from Lungs in Mice. J Biol Chem. 2016;291:8070-89 pubmed publisher
Turner C, Badu Nkansah K, Crowley D, van der Flier A, Hynes R. α5 and αv integrins cooperate to regulate vascular smooth muscle and neural crest functions in vivo. Development. 2015;142:797-808 pubmed publisher
Fedele C, Singh A, Zerlanko B, Iozzo R, Languino L. The αvβ6 integrin is transferred intercellularly via exosomes. J Biol Chem. 2015;290:4545-51 pubmed publisher
Ballesteros A, Mentink Kane M, Warren J, Kaplan G, Dveksler G. Induction and activation of latent transforming growth factor-β1 are carried out by two distinct domains of pregnancy-specific glycoprotein 1 (PSG1). J Biol Chem. 2015;290:4422-31 pubmed publisher
Guha R, Das S, Ghosh J, Sundar S, Dujardin J, Roy S. Antimony resistant Leishmania donovani but not sensitive ones drives greater frequency of potent T-regulatory cells upon interaction with human PBMCs: role of IL-10 and TGF-β in early immune response. PLoS Negl Trop Dis. 2014;8:e2995 pubmed publisher
Dutta A, Li J, Lu H, Akech J, Pratap J, Wang T, et al. Integrin ?v?6 promotes an osteolytic program in cancer cells by upregulating MMP2. Cancer Res. 2014;74:1598-608 pubmed publisher
Mele V, Muraro M, Calabrese D, Pfaff D, Amatruda N, Amicarella F, et al. Mesenchymal stromal cells induce epithelial-to-mesenchymal transition in human colorectal cancer cells through the expression of surface-bound TGF-?. Int J Cancer. 2014;134:2583-94 pubmed publisher
Willet J, Pichitsiri W, Jenkinson S, Brain J, Wood K, Alhasan A, et al. Kidney transplantation: analysis of the expression and T cell-mediated activation of latent TGF-β. J Leukoc Biol. 2013;93:471-8 pubmed publisher
Yamazaki S, Ema H, Karlsson G, Yamaguchi T, Miyoshi H, Shioda S, et al. Nonmyelinating Schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche. Cell. 2011;147:1146-58 pubmed publisher
Oida T, Weiner H. Overexpression of TGF-ß 1 gene induces cell surface localized glucose-regulated protein 78-associated latency-associated peptide/TGF-ß. J Immunol. 2010;185:3529-35 pubmed publisher
Tran D, Glass D, Uzel G, Darnell D, Spalding C, Holland S, et al. Analysis of adhesion molecules, target cells, and role of IL-2 in human FOXP3+ regulatory T cell suppressor function. J Immunol. 2009;182:2929-38 pubmed publisher
Savage N, De Boer T, Walburg K, Joosten S, van Meijgaarden K, Geluk A, et al. Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1. J Immunol. 2008;181:2220-6 pubmed
Rojas A, Meherem S, Kim Y, Washington M, Willis J, Markowitz S, et al. The aberrant methylation of TSP1 suppresses TGF-beta1 activation in colorectal cancer. Int J Cancer. 2008;123:14-21 pubmed publisher
Van Aarsen L, Leone D, Ho S, Dolinski B, McCoon P, Lepage D, et al. Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism. Cancer Res. 2008;68:561-70 pubmed publisher
Godfrey W, Spoden D, Ge Y, Baker S, Liu B, Levine B, et al. Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood. 2005;105:750-8 pubmed
Nakamura K, Kitani A, Fuss I, Pedersen A, Harada N, Nawata H, et al. TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol. 2004;172:834-42 pubmed
Zhang Y, McCormick L, Gilliam A. Latency-associated peptide prevents skin fibrosis in murine sclerodermatous graft-versus-host disease, a model for human scleroderma. J Invest Dermatol. 2003;121:713-9 pubmed
product information
brand :
R&D Systems, a Bio-Techne Brand
catalog number base :
246-LP
SKU :
246-LP-025
product name :
Recombinant Human LAP (TGF-beta 1) Protein
Description :
The Recombinant Human LAP (TGF-beta 1) Protein from R&D Systems is derived from Sf 21 (baculovirus). The Recombinant Human LAP (TGF-beta 1) Protein has been validated for the following applications: Bioactivity.
target :
LAP (TGF-beta 1)
category :
Proteins and Enzymes
unit size :
25 ug
buffer :
Lyophilized from a 0.2 µm filtered solution in PBS with BSA as a carrier protein.
conjugate :
Unconjugated
purity :
>97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
species :
Human
observed molecular weight :
28-36 kDa, reducing 60-70 kDa, non-reducing conditions (variably glycosylated)
theoretical molecular weight :
27 kDa (monomer)
gene symbol :
TGFB1
details of functionality :
Measured by its ability to inhibit TGF-beta 1 activity on HT-2 mouse T cells. Tsang, M. et al . (1995) Cytokine 7 :389. The ED50 for this effect is 50-300 ng/mL in the presence of 1 ng/mL of Recombinant Human TGF-beta 1 (Catalog # 240-B ).
endotoxin note :
<0.10 EU per 1 µg of the protein by the LAL method.
accessionNumbers :
P01137.2
applications :
Bioactivity
source :
Sf 21 (baculovirus)-derived Recombinant Human LAP (TGF-beta 1) Protein
USD :
470 USD
alt names :
CED, DPD1, LAP, LAP (TGFbeta 1), TGFB, TGFB1, TGFbeta, transforming growth factor beta 1
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
more info or order :
R&D Systems product webpage
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.